186 related articles for article (PubMed ID: 11380613)
1. Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions.
Suomela S; Kariniemi AL; Snellman E; Saarialho-Kere U
Exp Dermatol; 2001 Jun; 10(3):175-83. PubMed ID: 11380613
[TBL] [Abstract][Full Text] [Related]
2. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Salmela MT; Karjalainen-Lindsberg ML; Puolakkainen P; Saarialho-Kere U
Br J Cancer; 2001 Aug; 85(3):383-92. PubMed ID: 11487270
[TBL] [Abstract][Full Text] [Related]
3. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.
Vaalamo M; Karjalainen-Lindsberg ML; Puolakkainen P; Kere J; Saarialho-Kere U
Am J Pathol; 1998 Apr; 152(4):1005-14. PubMed ID: 9546361
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis.
Suomela S; Kariniemi AL; Impola U; Karvonen SL; Snellman E; Uurasmaa T; Peltonen J; Saarialho-Kere U
Acta Derm Venereol; 2003; 83(2):108-14. PubMed ID: 12735638
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
6. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
Salmela MT; MacDonald TT; Black D; Irvine B; Zhuma T; Saarialho-Kere U; Pender SL
Gut; 2002 Oct; 51(4):540-7. PubMed ID: 12235077
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
[TBL] [Abstract][Full Text] [Related]
10. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro.
Nelimarkka LO; Nikkari ST; Ravanti LS; Kähäri VM; Järveläinen HT
Matrix Biol; 1998 Aug; 17(4):293-304. PubMed ID: 9749945
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair.
Madlener M; Parks WC; Werner S
Exp Cell Res; 1998 Jul; 242(1):201-10. PubMed ID: 9665817
[TBL] [Abstract][Full Text] [Related]
12. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
Kranzhöfer A; Baker AH; George SJ; Newby AC
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
[TBL] [Abstract][Full Text] [Related]
13. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
Ye HQ; Azar DT
Invest Ophthalmol Vis Sci; 1998 May; 39(6):913-21. PubMed ID: 9579471
[TBL] [Abstract][Full Text] [Related]
14. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers.
Saarialho-Kere UK
Arch Dermatol Res; 1998 Jul; 290 Suppl():S47-54. PubMed ID: 9710383
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
Steen B; Sejersen S; Berglin L; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2194-200. PubMed ID: 9761302
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
17. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
Reynolds JJ
Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
[TBL] [Abstract][Full Text] [Related]
18. Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2.
Fleischmajer R; Kuroda K; Hazan R; Gordon RE; Lebwohl MG; Sapadin AN; Unda F; Iehara N; Yamada Y
J Invest Dermatol; 2000 Nov; 115(5):771-7. PubMed ID: 11069613
[TBL] [Abstract][Full Text] [Related]
19. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration.
Vaalamo M; Kariniemi AL; Shapiro SD; Saarialho-Kere U
J Invest Dermatol; 1999 Apr; 112(4):499-505. PubMed ID: 10201535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
